Jiangsu Apon Medical Technology Co Ltd Class A Asset Resilience Ratio

Latest as of June 2025: 1.44%

Jiangsu Apon Medical Technology Co Ltd Class A asset resilience ratio. Jiangsu Apon Medical Technology Co Ltd Class A (300753) has an Asset Resilience Ratio of 1.44% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jiangsu Apon Medical Technology Co Ltd C (300753) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥12.00 Million
≈ $1.76 Million USD Cash + Short-term Investments

Total Assets

CN¥832.30 Million
≈ $121.79 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Jiangsu Apon Medical Technology Co Ltd Class A (2023–2024)

Asset resilience ratio of Jiangsu Apon Medical Technology Co Ltd Class A from 2023 to 2024. This chart shows how Jiangsu Apon Medical Technology Co Ltd Class A's Asset Resilience Ratio has changed over time. Read 300753 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Apon Medical Technology Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Jiangsu Apon Medical Technology Co Ltd C's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥12.00 Million 1.44%
Total Liquid Assets CN¥12.00 Million 1.44%

Asset Resilience Insights

  • Limited Liquidity: Jiangsu Apon Medical Technology Co Ltd Class A maintains only 1.44% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Jiangsu Apon Medical Technology Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Jiangsu Apon Medical Technology Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Autek China Inc
SHE:300595
Medical Instruments & Supplies 21.20%
Pegavision
TW:6491
Medical Instruments & Supplies 17.14%
Crossject
PA:ALCJ
Medical Instruments & Supplies 1.31%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.29%

Jiangsu Apon Medical Technology Co Ltd Class A Asset Resilience Ratio by Year (2023–2024)

Jiangsu Apon Medical Technology Co Ltd Class A asset resilience ratio by year from 2023 to 2024. The table below shows the annual Asset Resilience Ratio data for Jiangsu Apon Medical Technology Co Ltd Class A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.12% CN¥1.00 Million
≈ $146.33K
CN¥863.49 Million
≈ $126.36 Million
0.00pp
2023-12-31 0.12% CN¥1.00 Million
≈ $146.33K
CN¥859.57 Million
≈ $125.78 Million
--
pp = percentage points

About Jiangsu Apon Medical Technology Co Ltd Class A

SHE:300753 China Medical Instruments & Supplies
Market Cap
$366.31 Million
CN¥2.50 Billion CNY
Market Cap Rank
#13594 Global
#3996 in China
Share Price
CN¥19.86
Change (1 day)
+1.90%
52-Week Range
CN¥18.16 - CN¥43.19
All Time High
CN¥43.19
About

Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company's principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiang… Read more